These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 16208816)

  • 1. HAART at 10--a CFA timeline.
    Res Initiat Treat Action; 2005; 11(1):6-27. PubMed ID: 16208816
    [No Abstract]   [Full Text] [Related]  

  • 2. Ten years of HAART.
    Harrington M
    Res Initiat Treat Action; 2005; 11(1):28-38. PubMed ID: 16208817
    [No Abstract]   [Full Text] [Related]  

  • 3. HAART at 10: an interview with Cal Cohen.
    Cohen C
    Res Initiat Treat Action; 2005; 11(1):49-51. PubMed ID: 16208821
    [No Abstract]   [Full Text] [Related]  

  • 4. HAART at 10: an interview with Joseph Gathe.
    Gathe J
    Res Initiat Treat Action; 2005; 11(1):46-8. PubMed ID: 16208820
    [No Abstract]   [Full Text] [Related]  

  • 5. HIV at twenty five and counting.
    Muzyka BC
    Pract Proced Aesthet Dent; 2007; 19(1):15. PubMed ID: 17402626
    [No Abstract]   [Full Text] [Related]  

  • 6. The chronicles of HIV therapeutics: where to begin, when to start and how will it end--a tale of two decades and beyond?
    Phillips EJ; Tseng A
    Can J Clin Pharmacol; 2002; 9(3):120-2. PubMed ID: 12422248
    [No Abstract]   [Full Text] [Related]  

  • 7. Twenty-five years of translational medicine in antiretroviral therapy: promises to keep.
    Broder S
    Sci Transl Med; 2010 Jul; 2(39):39ps33. PubMed ID: 20610849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Food and Drug Administration: 100 years of protection.
    Mosocco DJ
    Home Healthc Nurse; 2007 Mar; 25(3):148-50. PubMed ID: 17353704
    [No Abstract]   [Full Text] [Related]  

  • 9. HIV/AIDS in the last 10 years.
    Osman AS
    East Mediterr Health J; 2008; 14 Suppl():S90-6. PubMed ID: 19205608
    [No Abstract]   [Full Text] [Related]  

  • 10. Social norms and the evolution of drug regulation in the U.S.: implications for access to medications for HIV disease.
    Smith SR; Kirking DM
    AIDS Public Policy J; 1999; 14(3):105-16. PubMed ID: 10935047
    [No Abstract]   [Full Text] [Related]  

  • 11. Cancer drug approval in the United States, Europe, and Japan.
    Milsted RA
    Adv Cancer Res; 2007; 96():371-91. PubMed ID: 17161686
    [No Abstract]   [Full Text] [Related]  

  • 12. Adefovir rejected.
    Res Initiat Treat Action; 1999 Dec; 5(5):23. PubMed ID: 11366890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antiretroviral treatment of HIV infections in 2001].
    Frøland SS
    Tidsskr Nor Laegeforen; 2001 Nov; 121(29):3363. PubMed ID: 11826773
    [No Abstract]   [Full Text] [Related]  

  • 14. As the tide turns: the changing HIV/AIDS epidemic and the criminalization of HIV exposure.
    McArthur JB
    Cornell Law Rev; 2009 Mar; 94(3):707-42. PubMed ID: 19507336
    [No Abstract]   [Full Text] [Related]  

  • 15. FDA centennial.
    Kennedy D
    Science; 2006 Apr; 312(5770):19. PubMed ID: 16601155
    [No Abstract]   [Full Text] [Related]  

  • 16. FDA meeting on approving immune therapies: background and comment.
    James JS
    AIDS Treat News; 2000 Oct; (353):3-7. PubMed ID: 12173555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is it time to rethink the expanded-access programs for HIV infection?
    Amorosa V; Tebas P
    J Infect Dis; 2007 Oct; 196(7):974-7. PubMed ID: 17763316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [25 years of the AIDS epidemic].
    Frøland SS
    Tidsskr Nor Laegeforen; 2006 Nov; 126(23):3140-4. PubMed ID: 17160123
    [No Abstract]   [Full Text] [Related]  

  • 19. Initiating highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children in Europe and the United States: comparing clinical practice to guidelines and literature evidence.
    Verweel G; Saavedra-Lozano J; van Rossum AM; Ramilo O; de Groot R
    Pediatr Infect Dis J; 2006 Nov; 25(11):987-94. PubMed ID: 17072119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Losing deference in the FDA's second century: judicial review, politics, and a diminished legacy of expertise.
    O'Reilly JT
    Cornell Law Rev; 2008 Jul; 93(5):939-80. PubMed ID: 18618965
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.